Global Anti-influenza Drugs Market Growth (Status and Outlook) 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Anti-influenza Drugs will have significant change from previous year. By the most conservative estimates of global Anti-influenza Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Anti-influenza Drugs market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-influenza Drugs market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Anti-influenza Drugs, covering the supply chain analysis, impact assessment to the Anti-influenza Drugs market size growth rate in several scenarios, and the measures to be undertaken by Anti-influenza Drugs companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Oseltamivir
Zanamivir
Peramivir
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Children
Adults
Elderly
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
HEC Pharm
GlaxoSmithKline
Guangzhou Pharmaceutical
Shanghai Zhongxisanwei
Hunan Nucien Pharmaceutical
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Anti-influenza Drugs market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Anti-influenza Drugs market by identifying its various subsegments.
Focuses on the key global Anti-influenza Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anti-influenza Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Anti-influenza Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
1.7 What is the Impact of Covid-19 Outbreak On the Anti-influenza Drugs?
1.7.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.7.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.7.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Anti-influenza Drugs Market Size in 2020, by Scenario
1.7.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-influenza Drugs Market Size 2015-2025
2.1.2 Anti-influenza Drugs Market Size CAGR by Region
2.2 Anti-influenza Drugs Segment by Type
2.2.1 Oseltamivir
2.2.2 Oseltamivir
2.2.3 Peramivir
2.2.4 Other
2.3 Anti-influenza Drugs Market Size by Type
2.3.1 Global Anti-influenza Drugs Market Size Market Share by Type (2015-2020)
2.3.2 Global Anti-influenza Drugs Market Size Growth Rate by Type (2015-2020)
2.4 Anti-influenza Drugs Segment by Application
2.4.1 Children
2.4.2 Adults
2.4.3 Elderly
2.5 Anti-influenza Drugs Market Size by Application
2.5.1 Global Anti-influenza Drugs Market Size Market Share by Application (2015-2020)
2.5.2 Global Anti-influenza Drugs Market Size Growth Rate by Application (2015-2020)
3 Global Anti-influenza Drugs by Players
3.1 Global Anti-influenza Drugs Market Size Market Share by Players
3.1.1 Global Anti-influenza Drugs Market Size by Players (2018-2020)
3.1.2 Global Anti-influenza Drugs Market Size Market Share by Players (2018-2020)
3.2 Global Anti-influenza Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Anti-influenza Drugs by Regions
4.1 Anti-influenza Drugs Market Size by Regions
4.2 Americas Anti-influenza Drugs Market Size Growth
4.3 APAC Anti-influenza Drugs Market Size Growth
4.4 Europe Anti-influenza Drugs Market Size Growth
4.5 Middle East & Africa Anti-influenza Drugs Market Size Growth
5 Americas
5.1 Americas Anti-influenza Drugs Market Size by Countries
5.2 Americas Anti-influenza Drugs Market Size by Type
5.3 Americas Anti-influenza Drugs Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Anti-influenza Drugs Market Size by Regions
6.2 APAC Anti-influenza Drugs Market Size by Type
6.3 APAC Anti-influenza Drugs Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Anti-influenza Drugs by Countries
7.2 Europe Anti-influenza Drugs Market Size by Type
7.3 Europe Anti-influenza Drugs Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Anti-influenza Drugs by Countries
8.2 Middle East & Africa Anti-influenza Drugs Market Size by Type
8.3 Middle East & Africa Anti-influenza Drugs Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Anti-influenza Drugs Market Forecast
10.1 Global Anti-influenza Drugs Market Size Forecast (2021-2025)
10.2 Global Anti-influenza Drugs Forecast by Regions
10.2.1 Global Anti-influenza Drugs Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Anti-influenza Drugs Forecast by Type
10.8 Global Anti-influenza Drugs Forecast by Application
11 Key Players Analysis
11.1 Roche
11.1.1 Company Details
11.1.2 Anti-influenza Drugs Product Offered
11.1.3 Roche Anti-influenza Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Roche News
11.2 HEC Pharm
11.2.1 Company Details
11.2.2 Anti-influenza Drugs Product Offered
11.2.3 HEC Pharm Anti-influenza Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 HEC Pharm News
11.3 GlaxoSmithKline
11.3.1 Company Details
11.3.2 Anti-influenza Drugs Product Offered
11.3.3 GlaxoSmithKline Anti-influenza Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 GlaxoSmithKline News
11.4 Guangzhou Pharmaceutical
11.4.1 Company Details
11.4.2 Anti-influenza Drugs Product Offered
11.4.3 Guangzhou Pharmaceutical Anti-influenza Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Guangzhou Pharmaceutical News
11.5 Shanghai Zhongxisanwei
11.5.1 Company Details
11.5.2 Anti-influenza Drugs Product Offered
11.5.3 Shanghai Zhongxisanwei Anti-influenza Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Shanghai Zhongxisanwei News
11.6 Hunan Nucien Pharmaceutical
11.6.1 Company Details
11.6.2 Anti-influenza Drugs Product Offered
11.6.3 Hunan Nucien Pharmaceutical Anti-influenza Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Hunan Nucien Pharmaceutical News
...
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Anti-influenza Drugs Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Anti-influenza Drugs Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Anti-influenza Drugs Market Size CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Oseltamivir
Table 7. Major Players of Zanamivir
Table 8. Major Players of Peramivir
Table 9. Major Players of Other
Table 10. Anti-influenza Drugs Market Size by Type (2014-2019) ($ Millions)
Table 11. Global Anti-influenza Drugs Market Size Market Share by Type (2015-2020)
Table 12. Global Anti-influenza Drugs Market Size by Application (2015-2020) ($ Millions)
Table 13. Global Anti-influenza Drugs Market Size Market Share by Application (2015-2020)
Table 14. Global Anti-influenza Drugs Revenue by Players (2018-2020) ($ Millions)
Table 15. Global Anti-influenza Drugs Revenue Market Share by Players (2018-2020)
Table 16. Global Anti-influenza Drugs Key Players Head office and Products Offered
Table 17. Anti-influenza Drugs Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Anti-influenza Drugs Market Size by Regions 2015-2020 ($ Millions)
Table 21. Global Anti-influenza Drugs Market Size Market Share by Regions 2015-2020
Table 22. Americas Anti-influenza Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 23. Americas Anti-influenza Drugs Market Size Market Share by Countries (2015-2020)
Table 24. Americas Anti-influenza Drugs Market Size by Type (2015-2020) ($ Millions)
Table 25. Americas Anti-influenza Drugs Market Size Market Share by Type (2015-2020)
Table 26. Americas Anti-influenza Drugs Market Size by Application (2015-2020) ($ Millions)
Table 27. Americas Anti-influenza Drugs Market Size Market Share by Application (2015-2020)
Table 28. APAC Anti-influenza Drugs Market Size by Regions (2015-2020) ($ Millions)
Table 29. APAC Anti-influenza Drugs Market Size Market Share by Regions (2015-2020)
Table 30. APAC Anti-influenza Drugs Market Size by Type (2015-2020) ($ Millions)
Table 31. APAC Anti-influenza Drugs Market Size Market Share by Type (2015-2020)
Table 32. APAC Anti-influenza Drugs Market Size by Application (2015-2020) ($ Millions)
Table 33. APAC Anti-influenza Drugs Market Size Market Share by Application (2015-2020)
Table 34. Europe Anti-influenza Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 35. Europe Anti-influenza Drugs Market Size Market Share by Countries (2015-2020)
Table 36. Europe Anti-influenza Drugs Market Size by Type (2015-2020) ($ Millions)
Table 37. Europe Anti-influenza Drugs Market Size Market Share by Type (2015-2020)
Table 38. Europe Anti-influenza Drugs Market Size by Application (2015-2020) ($ Millions)
Table 39. Europe Anti-influenza Drugs Market Size Market Share by Application (2015-2020)
Table 40. Middle East & Africa Anti-influenza Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 41. Middle East & Africa Anti-influenza Drugs Market Size Market Share by Countries (2015-2020)
Table 42. Middle East & Africa Anti-influenza Drugs Market Size by Type (2015-2020) ($ Millions)
Table 43. Middle East & Africa Anti-influenza Drugs Market Size Market Share by Type (2015-2020)
Table 44. Middle East & Africa Anti-influenza Drugs Market Size by Application (2015-2020) ($ Millions)
Table 45. Middle East & Africa Anti-influenza Drugs Market Size Market Share by Application (2015-2020)
Table 46. Key and Potential Regions of Anti-influenza Drugs
Table 47. Key Application and Potential Industries of Anti-influenza Drugs
Table 48. Key Challenges of Anti-influenza Drugs
Table 49. Key Trends of Anti-influenza Drugs
Table 50. Global Anti-influenza Drugs Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 51. Global Anti-influenza Drugs Market Size Market Share Forecast by Regions
Table 52. Global Anti-influenza Drugs Market Size Forecast by Type (2021-2025) ($ Millions)
Table 53. Global Anti-influenza Drugs Market Size Market Share Forecast by Type (2021-2025)
Table 54. Global Anti-influenza Drugs Market Size Forecast by Application (2021-2025) ($ Millions)
Table 55. Global Anti-influenza Drugs Market Size Market Share Forecast by Application (2021-2025)
Table 56. Roche Details, Company Total Revenue (in $ million), Head Office, Anti-influenza Drugs Major Market Areas and Its Competitors
Table 57. Roche Anti-influenza Drugs Product Offered
Table 58. Roche Anti-influenza Drugs Revenue and Gross Margin (2018-2020E)
Table 59. Roche Main Business
Table 60. Roche Latest Developments
Table 61. HEC Pharm Details, Company Total Revenue (in $ million), Head Office, Anti-influenza Drugs Major Market Areas and Its Competitors
Table 62. HEC Pharm Anti-influenza Drugs Product Offered
Table 63. HEC Pharm Main Business
Table 64. HEC Pharm Anti-influenza Drugs Revenue and Gross Margin (2018-2020E)
Table 65. HEC Pharm Latest Developments
Table 66. GlaxoSmithKline Details, Company Total Revenue (in $ million), Head Office, Anti-influenza Drugs Major Market Areas and Its Competitors
Table 67. GlaxoSmithKline Anti-influenza Drugs Product Offered
Table 68. GlaxoSmithKline Main Business
Table 69. GlaxoSmithKline Anti-influenza Drugs Revenue and Gross Margin (2018-2020E)
Table 70. GlaxoSmithKline Latest Developments
Table 71. Guangzhou Pharmaceutical Details, Company Total Revenue (in $ million), Head Office, Anti-influenza Drugs Major Market Areas and Its Competitors
Table 72. Guangzhou Pharmaceutical Anti-influenza Drugs Product Offered
Table 73. Guangzhou Pharmaceutical Main Business
Table 74. Guangzhou Pharmaceutical Anti-influenza Drugs Revenue and Gross Margin (2018-2020E)
Table 75. Guangzhou Pharmaceutical Latest Developments
Table 76. Shanghai Zhongxisanwei Details, Company Total Revenue (in $ million), Head Office, Anti-influenza Drugs Major Market Areas and Its Competitors
Table 77. Shanghai Zhongxisanwei Anti-influenza Drugs Product Offered
Table 78. Shanghai Zhongxisanwei Main Business
Table 79. Shanghai Zhongxisanwei Anti-influenza Drugs Revenue and Gross Margin (2018-2020E)
Table 80. Shanghai Zhongxisanwei Latest Developments
Table 81. Hunan Nucien Pharmaceutical Details, Company Total Revenue (in $ million), Head Office, Anti-influenza Drugs Major Market Areas and Its Competitors
Table 82. Hunan Nucien Pharmaceutical Anti-influenza Drugs Product Offered
Table 83. Hunan Nucien Pharmaceutical Main Business
Table 84. Hunan Nucien Pharmaceutical Anti-influenza Drugs Revenue and Gross Margin (2018-2020E)
Table 85. Hunan Nucien Pharmaceutical Latest Developments
List of Figures
Figure 1. Anti-influenza Drugs Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Anti-influenza Drugs Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Anti-influenza Drugs Market Size Market Share by Type (2015-2020)
Figure 5. Global Oseltamivir Market Size Growth Rate
Figure 6. Global Zanamivir Market Size Growth Rate
Figure 7. Global Peramivir Market Size Growth Rate
Figure 8. Global Other Market Size Growth Rate
Figure 9. Anti-influenza Drugs in Children
Figure 10. Global Anti-influenza Drugs Market: Children (2015-2020) ($ Millions)
Figure 11. Anti-influenza Drugs in Adults
Figure 12. Global Anti-influenza Drugs Market: Adults (2015-2020) ($ Millions)
Figure 13. Anti-influenza Drugs in Elderly
Figure 14. Global Anti-influenza Drugs Market: Elderly (2015-2020) ($ Millions)
Figure 15. Global Elderly YoY Growth ($ Millions)
Figure 16. Global Anti-influenza Drugs Market Size Market Share by Application in 2019
Figure 17. Global Anti-influenza Drugs Market Size Market Share by Regions 2015-2020
Figure 18. Americas Anti-influenza Drugs Market Size 2015-2020 ($ Millions)
Figure 19. APAC Anti-influenza Drugs Market Size 2015-2020 ($ Millions)
Figure 20. Europe Anti-influenza Drugs Market Size 2015-2020 ($ Millions)
Figure 21. Middle East & Africa Anti-influenza Drugs Market Size 2015-2020 ($ Millions)
Figure 22. Americas Anti-influenza Drugs Market Size Market Share by Countries in 2019
Figure 23. Americas Anti-influenza Drugs Market Size Market Share by Type in 2019
Figure 24. Americas Anti-influenza Drugs Market Size Market Share by Application in 2019
Figure 25. United States Anti-influenza Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 26. Canada Anti-influenza Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 27. Mexico Anti-influenza Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 28. APAC Anti-influenza Drugs Market Size Market Share by Regions in 2019
Figure 29. APAC Anti-influenza Drugs Market Size Market Share by Type in 2019
Figure 30. APAC Anti-influenza Drugs Market Size Market Share by Application in 2019
Figure 31. China Anti-influenza Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 32. Japan Anti-influenza Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 33. Korea Anti-influenza Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 34. Southeast Asia Anti-influenza Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 35. India Anti-influenza Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 36. Australia Anti-influenza Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 37. Europe Anti-influenza Drugs Market Size Market Share by Countries in 2019
Figure 38. Europe Anti-influenza Drugs Market Size Market Share by Type in 2019
Figure 39. Europe Anti-influenza Drugs Market Size Market Share by Application in 2019
Figure 40. Germany Anti-influenza Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 41. France Anti-influenza Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 42. UK Anti-influenza Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 43. Italy Anti-influenza Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 44. Russia Anti-influenza Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 45. Spain Anti-influenza Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 46. Middle East & Africa Anti-influenza Drugs Market Size Market Share by Countries in 2019
Figure 47. Middle East & Africa Anti-influenza Drugs Market Size Market Share by Type in 2019
Figure 48. Middle East & Africa Anti-influenza Drugs Market Size Market Share by Application in 2019
Figure 49. Egypt Anti-influenza Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 50. South Africa Anti-influenza Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 51. Israel Anti-influenza Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 52. Turkey Anti-influenza Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 53. GCC Countries Anti-influenza Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 54. Global Anti-influenza Drugs arket Size Forecast (2021-2025) ($ Millions)
Figure 55. Americas Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 56. APAC Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 57. Europe Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 58. Middle East & Africa Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 59. United States Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 60. Canada Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 61. Mexico Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 62. Brazil Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 63. China Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 64. Japan Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 65. Korea Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 66. Southeast Asia Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 67. India Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 68. Australia Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 69. Germany Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 70. France Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 71. UK Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 72. Italy Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 73. Russia Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 74. Spain Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 75. Egypt Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 76. South Africa Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 77. Israel Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 78. Turkey Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Figure 79. GCC Countries Anti-influenza Drugs Market Size 2021-2025 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets